In this study, we verified the hypothesis that the metabolic stress sensor TRIB3 collaborates with the oncoprotein PML-RARα to inhibit PPARγ activity and subsequently cause dyslipidemia in newly diagnosed APL patients. This evidence concerns the gene PML and acute promyelocytic leukemia.